Literature DB >> 2969005

LHRH agonists in IVF: different methods of utilization and comparison with previous ovulation stimulation treatments.

R Frydman1, I Parneix, J Belaisch-Allart, R Forman, A Hazout, H Fernandez, J Testart.   

Abstract

LHRH agonists are being increasingly used in ovulation stimulation protocols in IVF programmes. We have compared the results of two methods of utilization of LHRH agonists. In the long protocol, gonadotrophin stimulation was only commenced after a preliminary period of pituitary desensitization with LHRH agonist. In the short protocol, exogenous gonadotrophins were administered shortly after the start of LHRH agonist therapy, benefiting from the gonadotrophin flare-up effect. One-hundred-and-eighty-six patients were divided equally between the two treatments. There was no difference in the ovarian response on the day of HCG or the number of mature oocytes recovered. The cleavage rate of mature oocytes was higher in the short protocol (70, versus 56, P less than 0.01). The ongoing pregnancy rate per treatment cycle was similar in both groups (18, in the long protocol and 16, in the short protocol). Analysis of the luteal phases revealed a trend for higher progesterone values in the long protocol although this was only significant on the second day following oocyte retrieval. As the clinical results were similar other factors should be taken into account when deciding therapy. These include patient convenience, cost and side-effects. Other schedules of ovulation stimulation using LHRH agonists are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969005     DOI: 10.1093/oxfordjournals.humrep.a136744

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

Review 1.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 2.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.

Authors:  A B van de-Helder; F M Helmerhorst; A Blankhart; R Brand; C Waegemaekers; N Naaktgeboren
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

4.  The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).

Authors:  J H Segars; G A Hill; S H Bryan; C M Herbert; K G Osteen; B J Rogers; A C Wentz
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

Review 5.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

6.  Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.

Authors:  A S Penzias; F N Shamma; J N Gutmann; D B Seifer; A H DeCherney; G Lavy
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

7.  Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.

Authors:  B C Tarlatzis; G Grimbizis; F Pournaropoulos; J Bontis; S Lagos; G Pados; S Mantalenakis
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

8.  In vitro DNA fluorescence after in vitro fertilization (IVF) failure.

Authors:  B Van Wissen; C Eisenberg; P Debey; G Pennehouat; J Auger; O Bomsel-Helmreich
Journal:  J Assist Reprod Genet       Date:  1992-12       Impact factor: 3.412

9.  The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).

Authors:  Y Gonen; M Dirnfeld; S Goldman; M Koifman; H Abramovici
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-10

10.  A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF.

Authors:  S Gordts; C Van Turnhout; R Campo; P Puttemans; M Valkenburg; S Gordts
Journal:  Facts Views Vis Obgyn       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.